Logo

Antiviral Drugs Market Size, Share, and Growth Forecast 2026 - 2033

Antiviral Drugs Market by Product Type (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Others), by Brand Type (Branded, Generics), by Application (HIV, Hepatitis, Herpes, Influenza, Others), by Distribution Channel, by Regional Analysis, 2026 - 2033

ID: PMRREP33257
Calendar

May 2026

188 Pages

Author : Abhijeet Surwase

Healthcare
  1. Executive Summary
    1. Global Antiviral Drugs Market Snapshot 2026 and 2033
    2. Market Opportunity Assessment, 2026-2033, US$ Bn
    3. Key Market Trends
    4. Industry Developments and Key Market Events
    5. Demand Side and Supply Side Analysis
    6. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definitions
    2. Value Chain Analysis
    3. Macro-Economic Factors
      1. Global GDP Outlook
      2. Global Sectorial Outlook
      3. Global GDP Growth Outlook
    4. Forecast Factors - Relevance and Impact
    5. COVID-19 Impact Assessment
    6. PESTLE Analysis
    7. Porter's Five Forces Analysis
    8. Geopolitical Tensions: Market Impact
    9. Regulatory and Technology Landscape
  3. Market Dynamics
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Trends
  4. Global Antiviral Drugs Market Outlook: Historical (2020 - 2025) and Forecast (2026 - 2033)
    1. Key Highlights
    2. Global Antiviral Drugs Market Outlook: Product Type
      1. Introduction/Key Findings
      2. Historical Market Size (US$ Bn) Analysis by Product Type, 2020-2025
      3. Current Market Size (US$ Bn) Forecast, by Product Type, 2026-2033
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. Others
      4. Market Attractiveness Analysis: Product Type
    3. Global Antiviral Drugs Market Outlook: Brand Type
      1. Introduction/Key Findings
      2. Historical Market Size (US$ Bn) Analysis by Brand Type, 2020-2025
      3. Current Market Size (US$ Bn) Forecast, by Brand Type, 2026-2033
        1. Branded
        2. Generics
      4. Market Attractiveness Analysis: Brand Type
    4. Global Antiviral Drugs Market Outlook: Application
      1. Introduction/Key Findings
      2. Historical Market Size (US$ Bn) Analysis by Application, 2020-2025
      3. Current Market Size (US$ Bn) Forecast, by Application, 2026-2033
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Others
      4. Market Attractiveness Analysis: Application
    5. Global Antiviral Drugs Market Outlook: Distribution Channel
      1. Introduction/Key Findings
      2. Historical Market Size (US$ Bn) Analysis by Distribution Channel, 2020-2025
      3. Current Market Size (US$ Bn) Forecast, by Distribution Channel, 2026-2033
        1. Hospital Pharmacy
        2. Retails Pharmacy
        3. Online Pharmacy
      4. Market Attractiveness Analysis: Distribution Channel
  5. Global Antiviral Drugs Market Outlook: Region
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis by Region, 2020-2025
    3. Current Market Size (US$ Bn) Forecast, by Region, 2026-2033
      1. North America
      2. Europe
      3. East Asia
      4. South Asia & Oceania
      5. Latin America
      6. Middle East & Africa
    4. Market Attractiveness Analysis: Region
  6. North America Antiviral Drugs Market Outlook: Historical (2020 - 2025) and Forecast (2026 - 2033)
    1. Key Highlights
    2. North America Market Size (US$ Bn) Forecast, by Country, 2026-2033
      1. U.S.
      2. Canada
    3. North America Market Size (US$ Bn) Forecast, by Product Type, 2026-2033
      1. DNA Polymerase Inhibitors
      2. Reverse Transcriptase Inhibitors
      3. Protease Inhibitors
      4. Neuraminidase Inhibitors
      5. Others
    4. North America Market Size (US$ Bn) Forecast, by Brand Type, 2026-2033
      1. Branded
      2. Generics
    5. North America Market Size (US$ Bn) Forecast, by Application, 2026-2033
      1. HIV
      2. Hepatitis
      3. Herpes
      4. Influenza
      5. Others
    6. North America Market Size (US$ Bn) Forecast, by Distribution Channel, 2026-2033
      1. Hospital Pharmacy
      2. Retails Pharmacy
      3. Online Pharmacy
  7. Europe Antiviral Drugs Market Outlook: Historical (2020 - 2025) and Forecast (2026 - 2033)
    1. Key Highlights
    2. Europe Market Size (US$ Bn) Forecast, by Country, 2026-2033
      1. Germany
      2. Italy
      3. France
      4. U.K.
      5. Spain
      6. Russia
      7. Rest of Europe
    3. Europe Market Size (US$ Bn) Forecast, by Product Type, 2026-2033
      1. DNA Polymerase Inhibitors
      2. Reverse Transcriptase Inhibitors
      3. Protease Inhibitors
      4. Neuraminidase Inhibitors
      5. Others
    4. Europe Market Size (US$ Bn) Forecast, by Brand Type, 2026-2033
      1. Branded
      2. Generics
    5. Europe Market Size (US$ Bn) Forecast, by Application, 2026-2033
      1. HIV
      2. Hepatitis
      3. Herpes
      4. Influenza
      5. Others
    6. Europe Market Size (US$ Bn) Forecast, by Distribution Channel, 2026-2033
      1. Hospital Pharmacy
      2. Retails Pharmacy
      3. Online Pharmacy
  8. East Asia Antiviral Drugs Market Outlook: Historical (2020 - 2025) and Forecast (2026 - 2033)
    1. Key Highlights
    2. East Asia Market Size (US$ Bn) Forecast, by Country, 2026-2033
      1. China
      2. Japan
      3. South Korea
    3. East Asia Market Size (US$ Bn) Forecast, by Product Type, 2026-2033
      1. DNA Polymerase Inhibitors
      2. Reverse Transcriptase Inhibitors
      3. Protease Inhibitors
      4. Neuraminidase Inhibitors
      5. Others
    4. East Asia Market Size (US$ Bn) Forecast, by Brand Type, 2026-2033
      1. Branded
      2. Generics
    5. East Asia Market Size (US$ Bn) Forecast, by Application, 2026-2033
      1. HIV
      2. Hepatitis
      3. Herpes
      4. Influenza
      5. Others
    6. East Asia Market Size (US$ Bn) Forecast, by Distribution Channel, 2026-2033
      1. Hospital Pharmacy
      2. Retails Pharmacy
      3. Online Pharmacy
  9. South Asia & Oceania Antiviral Drugs Market Outlook: Historical (2020 - 2025) and Forecast (2026 - 2033)
    1. Key Highlights
    2. South Asia & Oceania Market Size (US$ Bn) Forecast, by Country, 2026-2033
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of SAO
    3. South Asia & Oceania Market Size (US$ Bn) Forecast, by Product Type, 2026-2033
      1. DNA Polymerase Inhibitors
      2. Reverse Transcriptase Inhibitors
      3. Protease Inhibitors
      4. Neuraminidase Inhibitors
      5. Others
    4. South Asia & Oceania Market Size (US$ Bn) Forecast, by Brand Type, 2026-2033
      1. Branded
      2. Generics
    5. South Asia & Oceania Market Size (US$ Bn) Forecast, by Application, 2026-2033
      1. HIV
      2. Hepatitis
      3. Herpes
      4. Influenza
      5. Others
    6. South Asia & Oceania Market Size (US$ Bn) Forecast, by Distribution Channel, 2026-2033
      1. Hospital Pharmacy
      2. Retails Pharmacy
      3. Online Pharmacy
  10. Latin America Antiviral Drugs Market Outlook: Historical (2020 - 2025) and Forecast (2026 - 2033)
    1. Key Highlights
    2. Latin America Market Size (US$ Bn) Forecast, by Country, 2026-2033
      1. Brazil
      2. Mexico
      3. Rest of LATAM
    3. Latin America Market Size (US$ Bn) Forecast, by Product Type, 2026-2033
      1. DNA Polymerase Inhibitors
      2. Reverse Transcriptase Inhibitors
      3. Protease Inhibitors
      4. Neuraminidase Inhibitors
      5. Others
    4. Latin America Market Size (US$ Bn) Forecast, by Brand Type, 2026-2033
      1. Branded
      2. Generics
    5. Latin America Market Size (US$ Bn) Forecast, by Application, 2026-2033
      1. HIV
      2. Hepatitis
      3. Herpes
      4. Influenza
      5. Others
    6. Latin America Market Size (US$ Bn) Forecast, by Distribution Channel, 2026-2033
      1. Hospital Pharmacy
      2. Retails Pharmacy
      3. Online Pharmacy
  11. Middle East & Africa Antiviral Drugs Market Outlook: Historical (2020 - 2025) and Forecast (2026 - 2033)
    1. Key Highlights
    2. Middle East & Africa Market Size (US$ Bn) Forecast, by Country, 2026-2033
      1. GCC Countries
      2. South Africa
      3. Northern Africa
      4. Rest of MEA
    3. Middle East & Africa Market Size (US$ Bn) Forecast, by Product Type, 2026-2033
      1. DNA Polymerase Inhibitors
      2. Reverse Transcriptase Inhibitors
      3. Protease Inhibitors
      4. Neuraminidase Inhibitors
      5. Others
    4. Middle East & Africa Market Size (US$ Bn) Forecast, by Brand Type, 2026-2033
      1. Branded
      2. Generics
    5. Middle East & Africa Market Size (US$ Bn) Forecast, by Application, 2026-2033
      1. HIV
      2. Hepatitis
      3. Herpes
      4. Influenza
      5. Others
    6. Middle East & Africa Market Size (US$ Bn) Forecast, by Distribution Channel, 2026-2033
      1. Hospital Pharmacy
      2. Retails Pharmacy
      3. Online Pharmacy
  12. Competition Landscape
    1. Market Share Analysis, 2025
    2. Market Structure
      1. Competition Intensity Mapping
      2. Competition Dashboard
    3. Company Profiles
      1. Gilead Sciences
        1. Company Overview
        2. Product Portfolio/Offerings
        3. Key Financials
        4. SWOT Analysis
        5. Company Strategy and Key Developments
      2. Pfizer
      3. AbbVie
      4. Merck & Co.
      5. Roche
      6. GSK plc
      7. Johnson & Johnson
      8. Bristol Myers Squibb
      9. Novartis
      10. Aurobindo Pharma
      11. Cipla
      12. Teva Pharmaceutical Industries
      13. Moderna
      14. Boehringer Ingelheim
      15. Others
  13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations
Emailsales@persistencemarketresearch.com
UK

Corporate Office

Persistence Research & Consultancy Services Limited

Company Number : 15310893

Second Floor, 150 Fleet Street,London, EC4A 2DQ.

+44 203-837-5656
USA

Regional Office

Persistence Market Research

108 W 39th Street, Ste 1006,PMB2219, New York, NY 10018

+1 646-878-6329
India

Global Research centre

Persistence Market Research Private Limited

CIN : U74900PN2014PTC153163

IT Unit No. 504, 5th Floor, IconTower, Baner, Pune - 411045.

+91 906 779 3500SIN : +65 6531 3894 98
Quick Links
CareersTerms & ConditionsReturn PolicyMarket Research Report
Customer FAQ’sPrivacy PolicySitemap

Copyright © 2026 Persistence Market Research. All Rights Reserved

Connect With Us -